RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

Triple-negative breast cancer (TNBC) stands out as the most aggressive subtype within the spectrum of breast cancer. The current clinical guidelines propose treatment strategies involving cytotoxic agents like epirubicin or paclitaxel. However, the emergence of acquired resistance frequently precipi...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Fengxu Lv, Wentao Si, Xiaodan Xu, Xiaogang He, Ying Wang, Yetian Li, Feifei Li
التنسيق:	مقال
اللغة:	English
منشور في:	Elsevier 2024-02-01
سلاسل:	Neoplasia: An International Journal for Oncology Research
الموضوعات:	Triple negative breast cancer Chemoresistance Cancer stem cells RUNX2 TGF-β
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S1476558624000046

مواد مشابهة

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
حسب: Wentao Si, وآخرون
منشور في: (2022-11-01)

RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer
حسب: Natalia B. Fernández, وآخرون
منشور في: (2023-01-01)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
حسب: Bradley A. Hancock, وآخرون
منشور في: (2019-08-01)

Comprehensive Analysis of RUNX and TGF-β Mediated Regulation of Immune Cell Infiltration in Breast Cancer
حسب: Liang Gao, وآخرون
منشور في: (2021-08-01)

TGF-β induced reprogramming and drug resistance in triple-negative breast cells
حسب: Guoyu Wu, وآخرون
منشور في: (2022-04-01)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
حسب: Alexander H. Chung, وآخرون
منشور في: (2019-02-01)

DNA methylation affects metastasis of renal cancer and is associated with TGF-β/RUNX3 inhibition
حسب: Jianbo Zheng, وآخرون
منشور في: (2018-04-01)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
حسب: Meng Wang, وآخرون
منشور في: (2021-10-01)

Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
حسب: Anuradha Illendula, وآخرون
منشور في: (2016-06-01)

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
حسب: Margarite D. Matossian, وآخرون
منشور في: (2019-03-01)

Data mining analysis of miR-638 and key genes interaction in cisplatin resistant triple-negative breast cancer
حسب: Adam Hermawan, وآخرون
منشور في: (2019-12-01)

The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context
حسب: Adiba S. Khan, وآخرون
منشور في: (2023-02-01)

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
حسب: Shen-Jun Yuan, وآخرون
منشور في: (2019-10-01)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
حسب: Ling Wang, وآخرون
منشور في: (2018-07-01)

A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
حسب: Hitesh Kumar, وآخرون
منشور في: (2023-12-01)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
حسب: Liu C, وآخرون
منشور في: (2020-12-01)

A clinicopathologic study of triple negative breast cancer
حسب: Vandana L Gaopande, وآخرون
منشور في: (2015-01-01)

IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
حسب: Nicholas R. Hum, وآخرون
منشور في: (2022-07-01)

Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
حسب: Andrew Sulaiman, وآخرون
منشور في: (2021-10-01)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
حسب: Alaa M. Ghallab, وآخرون
منشور في: (2022-04-01)

Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer
حسب: Lei Di, وآخرون
منشور في: (2019-03-01)

TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
حسب: Weiguang Liu, وآخرون
منشور في: (2019-09-01)

RUNX regulated immune-associated genes predicts prognosis in breast cancer
حسب: Jingyue Fu, وآخرون
منشور في: (2022-08-01)

M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer
حسب: Xi Liu, وآخرون
منشور في: (2024-02-01)

CD74-AKT Axis Is a Potential Therapeutic Target in Triple-Negative Breast Cancer
حسب: Jingchao Wang, وآخرون
منشور في: (2024-06-01)

Role of eIF4A1 in triple‐negative breast cancer stem‐like cell‐mediated drug resistance
حسب: Dayanidhi Raman, وآخرون
منشور في: (2022-12-01)

Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines
حسب: Ammar Said Suliman, وآخرون
منشور في: (2021-01-01)

Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
حسب: Yen-Dun Tony Tzeng, وآخرون
منشور في: (2018-11-01)

TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
حسب: Weiguang Liu, وآخرون
منشور في: (2019-07-01)

Current approaches in treatment of triple-negative breast cancer
حسب: Hanan Ahmed Wahba, وآخرون
منشور في: (2015-06-01)

Triple-Negative Breast Cancer Survival in Iranian Patients
حسب: Mahdi Aghili, وآخرون
منشور في: (2013-08-01)

Platinum chemotherapy for early triple-negative breast cancer
حسب: Sofia RE. Mason, وآخرون
منشور في: (2024-06-01)

Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
حسب: Srijan Basu, وآخرون
منشور في: (2023-11-01)

Is breast conservation superior to mastectomy in early stage triple negative breast cancer?
حسب: Omran Saifi, وآخرون
منشور في: (2022-04-01)

USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
حسب: Yueh-Te Lin, وآخرون
منشور في: (2022-10-01)

Immunotherapy Treatment for Triple Negative Breast Cancer
حسب: Elizabeth R. Berger, وآخرون
منشور في: (2021-08-01)

Immunohistochemical evaluation of osteopontin expression in triple-negative breast cancer
حسب: Magdalena Niedolistek, وآخرون
منشور في: (2020-04-01)

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
حسب: Lisa Agnello, وآخرون
منشور في: (2023-07-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
حسب: Mohammed Amrallah A., وآخرون
منشور في: (2021-05-01)

The Adipokine Visfatin Modulates Cancer Stem Cell Properties in Triple-Negative Breast Cancer
حسب: Yi-Fen Chiang, وآخرون
منشور في: (2023-01-01)